Abstract 60 Table 2

Table comparing the TTR seen in our AF cohort and that of published literature

No of patients on warfarin	F/U time	TTR	Compared with our cohort Chi Sq with yates correction p value <0.05 were considered significant

Dabigatran	6022	24 months	0.0124^*
Rivaroxaban	7133	23 months	0.0001^*
Apixaban	9081	22 months	0.0038^*
Edoxaban	7036	34 months	0.0209^*
Auricula
- Whole study	18391	12 months	0.9490
- AF cohort only	11770	12 months	0.9945